Federal judge blocks Pentagon from designating WuXi AppTec as a Chinese military-linked company

Aug 7, 2026

U.S. District Chief Judge James Boasberg has temporarily blocked the Pentagon from designating Chinese biotech giant WuXi AppTec Co. as a Chinese military company, ruling that the government lacked sufficient evidence and repeatedly misread facts. The designation had acted as a "scarlet letter," causing customers to cancel contracts. WuXi AppTec, which derives 70% of its revenue from the U.S. and has a majority-U.S. citizen leadership, welcomed the injunction as relief from immediate commercial harm.

Federal court injunction granted

▪U.S. District Chief Judge James Boasberg granted Chinese biotechnology company WuXi AppTec Co. a preliminary injunction on August 7, 2026, temporarily blocking the U.S. Defense Department from designating it as a Chinese military company.
▪Chief Judge James Boasberg ruled that WuXi AppTec Co. established a likelihood that the U.S. Defense Department's designation was arbitrary and capricious.

Pentagon blacklist expansion

▪Under recent U.S. law, the Defense Department is barred from contracting with blacklisted companies starting in August 2026, and cannot purchase their products or services via third parties beginning in 2027.
▪The U.S. Defense Department expanded its Chinese military company blacklist in June 2026 to include 188 companies, reflecting concerns that China's military could leverage the private sector for advancements.
▪The Pentagon's blacklist includes major Chinese companies such as Alibaba, Baidu, BYD, and NIO, and is updated at least annually.

WuXi US business operations

▪WuXi AppTec Co. employs approximately 450 people in the United States and serves more than 1,000 U.S. customers, with U.S. clients accounting for roughly 70 percent of its revenue in 2025.
▪A majority of the board and executive managers of WuXi AppTec Co. are United States citizens.
▪Founded in 2000, WuXi AppTec Co. has a market value of approximately $43 billion and provides services to more than 4,000 pharmaceutical and life-sciences companies globally.

Contract cancellations business impact

▪Chief Judge James Boasberg noted that the Pentagon's designation acted as a "scarlet letter," causing WuXi AppTec Co.'s customers and suppliers to cancel contracts and move business to competitors.
▪A spokesperson for WuXi AppTec Co. stated that the preliminary injunction relieves the company from immediate adverse consequences of the designation while its operations remain fully functional.

Insufficient evidence designation challenge

▪WuXi AppTec Co.'s lawsuit argued that the U.S. Defense Department's designation was arbitrary, capricious, unsupported by facts, and the product of political pressure.
▪Chief Judge James Boasberg ruled that the U.S. government lacked sufficient evidence to justify the designation, finding that defense officials repeatedly misread the evidence.